Their cooperation is expected to be "a big step forward" in their joint research and development in the areas of oncology, hematology, immunology, neurology and ophthalmology, Roche Hungary said.
Supporting education, sharing international experience and developing domestic practices will all play an important role in the joint work, which will focus on personalised medicine, value-based healthcare and data-driven healthcare decision-making, it added.
Roche has conducted around 70 clinical trials in various diseases with the university over the past five years, it said.
The agreement was signed by rector Béla Merkely and chancellor Lívia Pavlik on behalf of the university and managing director Raffaella Claudia Bondi on behalf of Roche Hungary.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
